Digital health companies seeking FDA approval must weigh access versus priceDigital health companies seeking FDA approval must weigh access versus priceDigital health companies seeking FDA approval must weigh access versus price

Digital health companies seeking FDA approval must weigh access versus price

As this $9 billion industry matures, payers should look beyond FDA approval when reviewing the efficacy of digital tools, with a federal imprimatur becoming solely a decision about how to market a product.

from Section Page News - Modern Healthcare https://ift.tt/3wQZZSz